S&P 500
(0.17%) 5 189.70 points
Dow Jones
(0.14%) 38 906 points
Nasdaq
(-0.06%) 16 340 points
Oil
(0.01%) $78.49
Gas
(0.82%) $2.21
Gold
(-0.41%) $2 321.70
Silver
(-0.37%) $27.51
Platinum
(2.49%) $988.90
USD/EUR
(0.15%) $0.930
USD/NOK
(0.73%) $10.90
USD/GBP
(0.43%) $0.799
USD/RUB
(-0.08%) $91.27

实时更新: Indivior PLC [INDV.L]

交易所: LSE 工业: Pharmaceuticals, Biotechnology & Life Sciences
最后更新时间7 May 2024 @ 23:37

-0.91% £ 1 422.00

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 23:37):

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders...

Stats
今日成交量 300 150
平均成交量 511 646
市值 1.93B
EPS £0 ( 2024-04-24 )
下一个收益日期 ( £0 ) 2024-07-25
Last Dividend £36.50 ( 2016-06-16 )
Next Dividend £0 ( N/A )
P/E 1 422.00
ATR14 £1.896 (0.13%)

音量 相关性

長: 0.11 (neutral)
短: 0.83 (strong)
Signal:(45.432) Same movement expected

Indivior PLC 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Indivior PLC 相关性 - 货币/商品

The country flag -0.62
( weak negative )
The country flag -0.57
( weak negative )
The country flag -0.63
( weak negative )
The country flag -0.49
( neutral )
The country flag 0.59
( weak )
The country flag 0.64
( weak )

Indivior PLC 财务报表

Annual 2023
营收: £1.09B
毛利润: £907.00M (82.98 %)
EPS: £0.0100
FY 2023
营收: £1.09B
毛利润: £907.00M (82.98 %)
EPS: £0.0100
FY 2022
营收: £901.00M
毛利润: £742.00M (82.35 %)
EPS: £-0.380
FY 2021
营收: £791.00M
毛利润: £664.00M (83.94 %)
EPS: £1.410

Financial Reports:

No articles found.

Indivior PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Indivior PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.48%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend £10.40 2015-09-17
Last Dividend £36.50 2016-06-16
Next Dividend £0 N/A
Payout Date 2016-07-29
Next Payout Date N/A
# dividends 2 --
Total Paid Out £46.90 --
Avg. Dividend % Per Year 0.00% --
Score 1.12 --
Div. Sustainability Score 4.95
Div.Growth Potential Score 0
Div. Directional Score 1.992 --
Next Divdend (Est)
(2024-07-15)
£0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.12
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TON.L Dividend Knight 2023-06-01 Annually 32 1.80%
LTHM.L Dividend Knight 2023-08-03 Semi-Annually 33 0.87%
COA.L Dividend Knight 2023-10-19 Annually 33 1.79%
ROR.L Dividend Knight 2023-08-17 Semi-Annually 32 1.43%
HHI.L Dividend King 2023-09-14 Quarterly 25 3.58%
AUTO.L Dividend Knight 2023-08-24 Annually 9 0.79%
VLX.L Dividend Knight 2023-07-20 Sporadic 32 0.82%
MRCH.L Dividend King 2023-07-06 Quarterly 53 3.07%
DIVI.L Dividend Knight 2023-09-28 Quarterly 14 1.99%
SHOE.L Dividend Knight 2023-07-13 Annually 10 2.57%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.001831.5009.9610.00[0 - 0.5]
returnOnAssetsTTM0.001021.2009.9710.00[0 - 0.3]
returnOnEquityTTM0.005421.500-1.051-1.576[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.9680.800-0.161-0.129[1 - 3]
quickRatioTTM0.5260.800-1.609-1.287[0.8 - 2.5]
cashRatioTTM0.2421.5009.7710.00[0.2 - 2]
debtRatioTTM0.144-1.5007.59-10.00[0 - 0.6]
interestCoverageTTM0.5531.000-0.906-0.906[3 - 30]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
freeCashFlowPerShareTTM-2.682.00-1.339-2.68[0 - 20]
debtEquityRatioTTM0.215-1.5009.14-10.00[0 - 2.5]
grossProfitMarginTTM0.8301.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.01921.000-1.616-1.616[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.1171.000-7.32-7.32[0.2 - 2]
assetTurnoverTTM0.5590.8009.607.68[0.5 - 2]
Total Score4.95

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM1 238.721.00010.000[1 - 100]
returnOnEquityTTM0.005422.50-0.676-1.576[0.1 - 1.5]
freeCashFlowPerShareTTM-2.682.00-0.892-2.68[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.2881.000-9.700[0.1 - 0.5]
Total Score-0.971

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。